New guideline focuses on the timing of hip and knee arthroplasty

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of its new guideline titled "the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Osteonecrosis Who Have Failed Nonoperative Therapy."

Related Keywords

United States ,American ,Susanm Goodman ,Charlesp Hannon ,Emily Henderson ,American Association Of Hip ,Patient Panel ,American College Of Rheumatology ,American College ,American Association ,Knee Surgeons ,Optimal Timing ,Elective Hip ,Knee Arthroplasty ,Symptomatic Moderate ,Severe Osteoarthritis ,Perioperative Management ,Antirheumatic Medication ,Rheumatic Diseases Undergoing Elective Total Hip ,Total Knee Arthroplasty ,Assistant Professor ,Orthopedic Surgery ,Washington University ,Special Surgery ,Arthroplasty ,Knee ,Arthritis ,Education ,Lupus ,Lupus Erythematosus ,Nicotine ,Osteoarthritis ,Osteonecrosis ,Perioperative ,Physical Therapy ,Research ,Rheumatoid Arthritis ,Heumatology ,Spondyloarthritis ,Surgery ,Systemic Lupus Erythematosus ,